Literature DB >> 9785223

Evidence for hypocholesterolemic effect of Lactobacillus reuteri in hypercholesterolemic mice.

M P Taranto1, M Medici, G Perdigon, A P Ruiz Holgado, G F Valdez.   

Abstract

Swiss Albino mice were fed a diet enriched with fat to produce hypercholesterolemia. The further administration of Lactobacillus reuteri CRL 1098 (10(4) cells/d) to hypercholesterolemic mice for 7 d decreased total cholesterol by 38%, producing serum cholesterol concentrations similar to that of the control group (67.4 mg/ml). This low dose of L. reuteri caused a 40% reduction in triglycerides and a 20% increase in the ratio of high density lipoprotein to low density lipoprotein without bacterial translocation of the native microflora into the spleen and liver. These data suggest that L. reuteri CRL 1098 is an effective hypocholesterolemic adjuvant at a low cell concentration for mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9785223     DOI: 10.3168/jds.S0022-0302(98)70123-7

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  26 in total

Review 1.  Bile salt hydrolase activity in probiotics.

Authors:  Máire Begley; Colin Hill; Cormac G M Gahan
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

2.  Evaluation of anti-colitic effect of lactic acid bacteria in mice by cDNA microarray analysis.

Authors:  Hoyong Lee; Young-Tae Ahn; Jung-Hee Lee; Chul-Sung Huh; Dong-Hyun Kim
Journal:  Inflammation       Date:  2009-12       Impact factor: 4.092

Review 3.  Cholesterol-Lowering Effects of Lactobacillus Species.

Authors:  Aditi Khare; Smriti Gaur
Journal:  Curr Microbiol       Date:  2020-02-04       Impact factor: 2.188

4.  Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis.

Authors:  Sahar K Hegazy; Mohamed M El-Bedewy
Journal:  World J Gastroenterol       Date:  2010-09-07       Impact factor: 5.742

5.  Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis.

Authors:  Jung-Hee Lee; Bomi Lee; Hye-Sung Lee; Eun-Ah Bae; Hoyong Lee; Young-Tae Ahn; Kwang-Sei Lim; Chul-Sung Huh; Dong-Hyun Kim
Journal:  Int J Colorectal Dis       Date:  2008-12-03       Impact factor: 2.571

6.  Bifidobacterium longum HY8004 attenuates TNBS-induced colitis by inhibiting lipid peroxidation in mice.

Authors:  In-Ah Lee; Eun-Ah Bae; Jung-Hee Lee; Hoyong Lee; Young-Tae Ahn; Chul-Sung Huh; Dong-Hyun Kim
Journal:  Inflamm Res       Date:  2009-11-01       Impact factor: 4.575

7.  Lactobacillus reuteri CRL1098 produces cobalamin.

Authors:  María P Taranto; José L Vera; Jeroen Hugenholtz; Graciela F De Valdez; Fernando Sesma
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

8.  Lactobacillus reuteri attenuates cardiac injury without lowering cholesterol in low-density lipoprotein receptor-deficient mice fed standard chow.

Authors:  Matthew Perry Koppinger; Marissa Anne Lopez-Pier; Rinku Skaria; Preston Royal Harris; John P Konhilas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-15       Impact factor: 4.733

9.  A Randomized Double-blind Controlled Trial of Lactobacillus acidophilus Plus Bifidobacterium bifidum versus Placebo in Patients with Hypercholesterolemia.

Authors:  Sanguansak Rerksuppaphol; Lakkana Rerksuppaphol
Journal:  J Clin Diagn Res       Date:  2015-03-01

10.  Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content.

Authors:  Do Kyung Lee; Seok Jang; Eun Hye Baek; Mi Jin Kim; Kyung Soon Lee; Hea Soon Shin; Myung Jun Chung; Jin Eung Kim; Kang Oh Lee; Nam Joo Ha
Journal:  Lipids Health Dis       Date:  2009-06-11       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.